Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA (MRK)

37
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
04/16/2014 04/17/2014 04/22/2014 04/23/2014 04/24/2014 Date
114.5(c) 115(c) 119.3(c) 119.5(c) 119.65(c) Last
289 721 270 559 351 261 265 741 290 787 Volume
+1.24% +0.44% +3.74% +0.17% +0.13% Change
More quotes
Company
Merck KGaA operates as a pharmaceutical, chemical and life science company, which is engages in the research and development of innovative drugs and chemicals. The company operates through four divisions: Merck Serono, Consumer Health, Performance Materials & Merck Millipore. The Merck Serono... 
Surperformance© rating of Merck KGaA
Trading Rating : Investor Rating :
More about the company
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 11 174 M
EBIT 2014 2 227 M
Net income 2014 1 462 M
Finance 2014 136 M
Yield 2014 1,67%
Sales 2015 11 354 M
EBIT 2015 2 269 M
Net income 2015 1 516 M
Finance 2015 1 124 M
Yield 2015 1,79%
PER 2014 19,49
PER 2015 18,61
EV / Sales 2014 0,68x
EV / Sales 2015 0,58x
Capitalization 7 732 M
More Financials
Latest news on MERCK KGAA
2d ago MERCK KGAA : Patent Issued for Calamitic Mesogenic Compounds
2d ago MERCK KGAA : Investigators at Merck KGaA Describe Findings in Prostate Cancer
2d ago MERCK KGAA : Form 8 (DD) - AZ Electronic Materials S.A.
3d ago AZ ELECTRONIC MATERIALS : Merck KGaA Extends Takeover Offer For AZ Electronic To..
4d ago MERCK KGAA : Serono's President %7E CEO Belén Garijo has Been Appointed to Board..
4d ago MERCK KGAA : Innovative Fertility Scorecard Measures "Fertility Friendliness" of..
04/17 MERCK KGAA : EMD Millipore Assigned Patent
04/16 ONCOTHYREON USA : Announces Merck KGaA, Darmstadt, Germany, Initiation of Phase ..
04/10 MERCK KGAA : EMD Serono, Inc. Launches 10th Edition of The EMD Serono Specialty ..
04/10 MERCK KGAA : EMD Serono Enters into Research Agreement with Pfizer and Broad Ins..
04/09 MERCK KGAA : EMD Millipore and VWR Extend Western European Distribution Agreemen..
04/07 MERCK KGAA : EMD Serono Announces Initiation of Phase III START2 Study with Tece..
More news
4-Traders Strategies on MERCK KGAA 
04/10Prices move higher as positive news are released
03/10A gap-filling is anticipated
More Strategies
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Technical analysis
Income Statement Evolution
Merck KGaA : Income Statement Evolution
More Financials
EPS Revisions
Merck KGaA : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF